QUILT-3.038: Active Immunotherapy CEA Vaccine in Patients With Malignancies Expressing CEA

NCT01147965 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer
Lung Cancer
Breast Cancer
Prostate Cancer

Interventions

BIOLOGICAL: Ad5 CEA Vaccine

Sponsor

NantCell, Inc.